TECHNOLOGY
Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
Ars TechnicaTuesday, October 13, 2026 at 10:48 PM
RedScroll Brief
"I can always find a couple of biotech stocks to smoke," Shkreli said in a livestream.
RedScroll Signal
- Impact
- High
- Category
- Technology
- Market relevance
- Moderate
- Why it matters
- Technology shifts change how people work, communicate, and build — often faster than policy can follow. "I can always find a couple of biotech stocks to smoke," Shkreli said in a livestream. Secondary effects may show up in markets and supply chains linked to Martin Shkreli and Technology.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
"I can always find a couple of biotech stocks to smoke," Shkreli said in a livestream.
Why it matters
Technology shifts change how people work, communicate, and build — often faster than policy can follow.
Background
Ars Technica reported on this under technology. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
Ars Technica published: Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to Martin Shkreli and Technology.
More on
Related stories
- SpaceX will try catching Starship and its booster for first time, Musk says
The VergeTECHNOLOGY
- Microsoft says AI agents are like insider threats as ‘frontier models can’t be trusted’
TechCrunchTECHNOLOGY
- Justice Department says North Koreans have infiltrated dozens of U.S. companies
TechCrunchTECHNOLOGY
- The Download: the claim shaking up AI and the internet’s agent problem
MIT Technology ReviewTECHNOLOGY
- How to study a swiftly melting climate disaster
MIT Technology ReviewTECHNOLOGY
- These startups hope “blended” food will cut our appetite for red meat
MIT Technology ReviewTECHNOLOGY
Source
Ars Technica
Original reporting by Ars Technica. RedScroll provides an extractive briefing only.